Oral Paclitaxel Efficacy Safety and PK in Recurrent and Metastatic Breast Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Bohuslav Melichar, M.D.
Onkologicka klinika, Fakultni nemocnice Olomouc (OUH)
Principal Investigator - Craig Gordon, D.O.
Michigan Center of Medical Research(MCMR)
Principal Investigator - David Weng, M.D.
Anne Arundel Health System Research Institute (AAHS)
Principal Investigator - Ghassan Aljazayrly, M.D.
California Research Institute (CRI)
Principal Investigator - Jane Skelton, M.D.
Boca Raton Regional Hospital (BRRH)
Principal Investigator - John Ellerton, M.D.
Nevada Cancer Research Foundation (NCRF)
Principal Investigator - Martin Smakal, M.D.
Onkologicky stacionar, NH Hospital a.s., nemocnice Horovice (NHH)
Principal Investigator - Martina Zimovjanova, M.D.
Onkologicka klinika, Vseobecna fakultni nemocnice v Praze (VFN)
Principal Investigator - Neelima Vidula, M.D.
Massachusetts General Hospital (MGH)
Principal Investigator - Priyanka Sharma, M.D.
University of Kansas Medical Center(KUMC)
Principal Investigator - Richard Caradonna, M.D.
ASCLEPES Research Center(ARC)
Principal Investigator - Timothy Pluard, M.D.
Saint Luke's Cancer Institute(SLCI)
Principal Investigator - Yan Ji, M.D.
Metro-Minnesota Community Oncology Research Consortium (MMCORC)
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Onkologicka Klinika, Fakultni Nemocnice Olomouc (ouh)
Olomouc, I.P. Pavlova 6, Czechia
- Onkologicky Stacionar, Nh Hospital A.S., Nemocnice Horovice (nhh)
Hořovice, K Nemocnici, Czechia
- Onkologicka Klinika, Vseobecna Fakultni Nemocnice V Praze (vfn)
Prague, U Nemocnice 499/2, Czechia
- California Research Institute (cri)
Los Angeles, California, United States
- University of California San Francisco (ucsf)
San Francisco, California, United States
- Boca Raton Regional Hospital (brrh)
Boca Raton, Florida, United States
- Asclepes Research Center(arc)
Weeki Wachee, Florida, United States
- Saint Luke'S Cancer Institute(slci)
Kansas City, Kansas, United States
- University of Kansas Medical Center(kumc)
Kansas City, Kansas, United States
- Anne Arundel Health System Research Institute (aahs)
Annapolis, Maryland, United States
- Massachusetts General Hospital(mgh)
Boston, Massachusetts, United States
- Michigan Center of Medical Research(mcmr)
Farmington Hills, Michigan, United States
- Metro-Minnesota Community Oncology Research Consortium (mmcorc)
Minneapolis, Minnesota, United States
- Nevada Cancer Research Foundation (ncrf)
Las Vegas, Nevada, United States
- University of Pittsburgh Medical Center (upmc)
Pittsburgh, Pennsylvania, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 6 Jul 2018
- Primary completion
- 13 Dec 2022
- Completion
- 13 Dec 2022
- Last update posted
- 16 Feb 2024
- Registered enrollment
- 72
- Registry id
- NCT03326102
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.